Evidence map›Paper›PMID 32404924›Full record

ArticleNature communications2020

Characterization of the development of the mouse cochlear epithelium at the single cell level.

Likhitha Kolla, Michael C Kelly, Zoe F Mann, Alejandro Anaya-Rocha, Kathryn Ellis, Abigail Lemons, Adam T Palermo, Kathy S So, Joseph C Mays, Joshua Orvis and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 2 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 2 syntheses or guidelines pooled it, 312 citations in OpenAlex.

  1. Utilizing Single Cell RNA-Sequencing to Implicate Cell Types and Therapeutic Targets for SSNHL in the Adult Cochlea.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Likhitha Kolla *Laboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.
Michael C Kelly *Laboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.
Zoe F MannCentre for Craniofacial and Regenerative Biology, King's College London, London, UK.ORCID http://orcid.org/0000-0002-4916-9574
Alejandro Anaya-RochaLaboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.
Kathryn EllisLaboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.
Abigail LemonsLaboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.
Adam T PalermoDecibel Therapeutics, 1325 Boylston, Str., Suite 500, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0001-9621-0157
Kathy S SoDecibel Therapeutics, 1325 Boylston, Str., Suite 500, Boston, MA, 02215, USA.
Joseph C MaysLaboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0003-4903-938X
Joshua OrvisInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Joseph C BurnsDecibel Therapeutics, 1325 Boylston, Str., Suite 500, Boston, MA, 02215, USA.
Ronna HertzanoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Elizabeth C DriverLaboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA.ORCID http://orcid.org/0000-0002-5618-1053
Matthew W KelleyLaboratory of Cochlear Development, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, 20892, USA. kelleymt@nidcd.nih.gov.ORCID http://orcid.org/0000-0001-7367-8697
National Institutes of Health · USDecImmune Therapeutics (United States) · USUniversity of Maryland, Baltimore · USKing's College London · GB

Funding

Hair Cell Development in the Mammalian CochleaZIADC000059 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI KELLEY, MATTHEW · 2009 to 2025
$41.8M
Cell Type Specific Transcriptional Cascades in Inner Ear DevelopmentR01DC013817 · NIDCD · UNIVERSITY OF MARYLAND BALTIMORE · PI HERTZANO, RONNA · 2015 to 2022
$3.6M
INTEGRATIVE MECHANISMS OF CORTICAL NEURONSR01DC000086 · NIDCD · YALE UNIVERSITY · PI SHEPHERD, GORDON · 1989 to 2010
$3.6M
Illuminating Neurodevelopment through Integrated Analysis and Vizualization of Multi-Omic DataR24MH114815 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI HERTZANO, RONNA, WHITE, OWEN R · 2018 to 2020
$2.3M
Hair Cell Development in the Mammalian CochleaZ01DC000059 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI KELLEY, MATTHEW W · 2000 to 2008
$1.9M
Cell Type Specific Transcriptional Cascades in Inner Ear DevelopmentU01DC013817 · NIDCD · UNIVERSITY OF MARYLAND BALTIMORE · PI AHMED, ZUBAIR M. · 2023 to 2025
$1.6M
POSTDOCTORAL RESEARCH TRAINING IN OTOLARYNGOLOGYT32DC000059 · NIDCD · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ANDERSON, JOHN H · 1999 to 2003
$453k
Intramural NIH HHS Z01 DC000059NIDCD NIH HHS R01 DC000086NIDCD NIH HHS R01 DC013817NIDCD NIH HHS T32 DC000059NIDCD NIH HHS U01 DC013817NIMH NIH HHS R24 MH114815
6 · The paper itself

Abstract

Mammalian hearing requires the development of the organ of Corti, a sensory epithelium comprising unique cell types. The limited number of each of these cell types, combined with their close proximity, has prevented characterization of individual cell types and/or their developmental progression. To examine cochlear development more closely, we transcriptionally profile approximately 30,000 isolated mouse cochlear cells collected at four developmental time points. Here we report on the analysis of those cells including the identification of both known and unknown cell types. Trajectory analysis for OHCs indicates four phases of gene expression while fate mapping of progenitor cells suggests that OHCs and their surrounding supporting cells arise from a distinct (lateral) progenitor pool. Tgfβr1 is identified as being expressed in lateral progenitor cells and a Tgfβr1 antagonist inhibits OHC development. These results provide insights regarding cochlear development and demonstrate the potential value and application of this data set.

Indexed as

AnimalsCells, CulturedCochleaGene Expression ProfilingGene Expression Regulation, DevelopmentalHair Cells, AuditoryHair Cells, Auditory, InnerHair Cells, Auditory, OuterMiceOrgan of CortiSingle-Cell AnalysisTime Factors

Identifiers

PMID32404924
PMCPMC7221106
OpenAlexW3024295806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.